AmebaGone Revenue and Competitors
Estimated Revenue & Valuation
- AmebaGone's estimated annual revenue is currently $620k per year.
- AmebaGone's estimated revenue per employee is $155,000
Employee Data
- AmebaGone has 4 Employees.
- AmebaGone grew their employee count by -33% last year.
AmebaGone's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder, President, CSO | Reveal Email/Phone |
2 | Lead Research Specialist | Reveal Email/Phone |
AmebaGone Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.8M | 18 | 20% | N/A | N/A |
#2 | $1.9M | 12 | 33% | N/A | N/A |
#3 | $1.1M | 7 | 0% | N/A | N/A |
#4 | $0.9M | 6 | 0% | N/A | N/A |
#5 | $5.2M | 67 | 0% | $45.5M | N/A |
#6 | $1.4M | 9 | 0% | N/A | N/A |
#7 | $1.6M | 10 | 0% | N/A | N/A |
#8 | $1.1M | 7 | 17% | N/A | N/A |
#9 | $13.5M | 87 | -17% | N/A | N/A |
#10 | $0.6M | 4 | -20% | N/A | N/A |
What Is AmebaGone?
AmebaGone uses naturally occurring, soil-dwelling amoebae (Dictyostelids) as drugs and disinfectants in agriculture, medicine, and industry. The amoebae kill bacteria, antibiotic-resistant or not, by consuming them as their food source. Additionally, the amoebae can break down biofilms and consume the bacteria within. Biofilms pose significant problems for agriculture, medicine, and industry because conventional antimicrobials and disinfectants have little to no effect against them. AmebaGone, Inc. is developing proprietary technologies that use a novel biocontrol method to destroy persistent bacterial infections. Potential applications include: 1) Reduction in agricultural disease such as fire blight in apples and soft rot in potatoes 2) Sterilization of medical devices, such as protection against Staphylococcus epidermidis 3) Treatment of wounds and infections from common pathogens such as Pseudomonas aeruginosa and Staphylococcus aureus, including MRSA 4) Protection of food-processing equipment and food itself from Escherichia coli, Salmonella enterica, Listeria monocytogenes, and other industrial contaminants.
keywords:N/AN/A
Total Funding
4
Number of Employees
$620k
Revenue (est)
-33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.5M | 4 | -89% | N/A |
#2 | $0.3M | 4 | N/A | N/A |
#3 | $0.3M | 4 | -33% | N/A |
#4 | $0.4M | 4 | 0% | N/A |
#5 | $0.8M | 4 | 0% | N/A |